Zero-COVID’s Long Shadow
From welded doors to mass PCR lines, health codes normalized surveillance. Factories ran 'closed loop'; protests of blank paper cracked the silence. Reopening whiplashed hospitals and supply chains. Vaccine diplomacy won fans, but mRNA lagged at home.
Episode Narrative
Title: Zero-COVID’s Long Shadow
In the blink of an eye, the landscape of China transformed from a tightly controlled economy to a dynamic labyrinth of growth, opportunity, and turbulence. The years from 1992 to 2003 marked a pivotal shift. Under the guiding vision of Deng Xiaoping, the nation's economic policies began to embrace what he termed a "socialist market economy." This evolution was no mere adjustment; it was a rite of passage, exposing the nation to global markets and ideas. With GDP growth averaging over 9% annually, the energy of China surged forth, propelling it into the spotlight as a formidable force on the world stage.
The late 1990s presented a wrenching test as the Asian Financial Crisis unfolded. Unlike many of its neighbors, China deftly avoided currency devaluation. This act of resilience was not just a survival maneuver, but a declaration of newfound strength. It paved the way for China’s entry into the World Trade Organization in 2001, a moment that would forever alter its economic landscape. The integration into global supply chains reverberated across borders, turning China into an export powerhouse. By 2018, the nation’s exports had skyrocketed from a modest $266 billion in 2001 to a staggering $2.5 trillion.
Yet, in the shadows of this growth lay vulnerabilities. The SARS outbreak in 2003 served as an unsettling alarm, revealing cracks in China's public health system. The event catalyzed an investment ripple — one that would later inform responses to future crises. The urgency to improve disease surveillance was a lesson learned, an echo of past suffering that signified the burgeoning importance of public health infrastructure.
As the world breathed a collective sigh of relief after the immediate impacts of SARS, another storm brewed on the horizon. The global financial crisis of 2008 unleashed a torrent of challenges, forcing China to roll out a massive $586 billion stimulus focused on infrastructure. While this aggressive approach stabilized growth, it also sowed the seeds of overcapacity and burgeoning debt across key sectors. Steel and cement, so vital for development, soon became burdens weighing heavily on the economy.
Into the 2010s, the dance between state and market continued. Corporate governance and capital market reforms advanced, yet state-owned enterprises remained central figures. This dichotomy carved a complicated path — one that promised both growth and persistent pitfalls, like capital misallocation, which stifled the vibrancy of private enterprise.
In 2013, President Xi Jinping unveiled the Belt and Road Initiative, a bold move that sought to not only expand China’s economic footprint but also extend its influence across continents. With promises exceeding $1 trillion in investments by 2025, this initiative illustrated a vision, one where China sought to weave itself into the very fabric of global commerce. The vast corridors of trade envisioned by this strategy laid the groundwork for a new chapter, linking nations through shared infrastructure and economic aspirations.
Enter 2015, a year that shifted gears with the "Made in China 2025" plan. This ambitious roadmap aimed to elevate China into the echelons of high-tech industries, dramatically boosting investments in sectors like robotics and green technology. This ambition wasn’t just about production; it was about innovation. The domestic market share surged, claiming nearly 78.4% in priority sectors, a testament to the advantageous positioning of China as a burgeoning technological powerhouse.
However, as the future appeared increasingly bright, beneath the surface, the implications of these strategies began to surface. From 2015 to 2025, nominal interest rates steadily fell, further complicating the landscape of capital allocation. As investment continued to pour into state-owned enterprises, the risk of misallocation loomed large, endangering the balance that was essential for sustainable growth.
Amid these layers of economic ambition, anti-corruption campaigns emerged between 2016 and 2020, targeting both the "tigers and flies." These initiatives aimed to instill greater discipline within the ranks of bureaucracy, yet they also centralized political authority. Faced with temptation and power, the fight against corruption morphed into a transformative force within the Party, shaping the contours of governance itself.
But as 2020 dawned, an unexpected adversary emerged — a microscopic virus that would send shockwaves throughout the globe. Born in Wuhan, COVID-19 represented not merely a health crisis but the manifestation of underlying tensions within the system. China responded with some of the strictest lockdowns the world had ever witnessed. Welded apartment doors, mass PCR testing, and an intricate web of health code apps began to reshape daily life. Surveillance became normalized, and public spaces transformed into checkpoints of compliance.
The implementation of "closed-loop" factory systems during lockdowns allowed exports to flow, yet it came at a cost of isolation for workers and led to supply chain bottlenecks, sending ripples across the global economy. As factories adjusted, the very fabric of international trade experienced a strain unlike any before.
Then, in 2022, a crack began to show — the rare protests against the extended Zero-COVID policies marked a pivotal moment in public sentiment. Demonstrators, armed with blank sheets of paper, wielded silence as their defiance against censorship and control. It was a stirring display of unity, a moment where the people, often subdued, found their voice in protest.
As 2022 transitioned into 2023, China’s abrupt departure from the Zero-COVID stance led to tumultuous times. A surge in cases overwhelmed hospitals, leading to scenes reminiscent of a new crisis. Manufacturing and logistics faced temporary disruptions, revealing vulnerabilities in the residual systems designed to contain the virus.
Throughout this turmoil, China didn't retreat from its global ambitions. By distributing over 3 billion doses of COVID-19 vaccines, the nation positioned itself as a beacon of "vaccine diplomacy," extending its influence into the Global South. Yet, the reliance on less effective inactivated vaccines delayed the transition to mRNA technology, illustrating the challenges faced by a nation striving to lead while grappling with its public health realities.
From 2023 to 2025, economic growth began to slow, averaging just 5.3%. Projections hinted at further decline, with estimates slipping to 2% by 2040. Behind these figures loomed structural challenges — an aging population and a debt overhang became the specters haunting policymakers as they navigated a landscape of shifting demographics and economic uncertainty.
As the journey continued, the narrative shifted toward corporate governance reforms that placed increasing importance on environmental, social, and governance metrics. However, even as these ideals gained momentum, disparities between regions persisted, revealing cracks within the ambitious facade.
By 2025, the solar panel and railway equipment sectors showcased China's ascent on the global stage, with 47.5% and 37.2% market shares, respectively. However, a critical vulnerability remained — a dependency on foreign semiconductors that cast a shadow over the remarkable achievements.
As life unfolded from 2020 to 2025, the legacy of health code apps lingered. What began as a tool for pandemic management turned into a haunting presence in urban spaces. The apparatus of surveillance became entrenched, required not only for entry into malls and metros but infiltrating the very fabric of daily existence.
The tapestry of these years weaves a poignant narrative — a story of resilience, ambition, and the echoes of decisions made in moments of crisis. Zero-COVID was not merely a policy; it was a reflection of the state’s intricate relationship with its people, a mirror reflecting both the strength and fragility of governance in the face of extraordinary circumstances.
As we consider the trajectory of China from the early 1990s to the unfolding present, a singular question emerges: In the pursuit of growth and power, have the lessons learned along this journey cast light on the precarious balance between control and freedom? The shadows of the past loom large, reminding us always that history is both a guide and a warning — a reminder that every action resonates through time, shaping tomorrow in ways we may yet come to understand.
Highlights
- 1992–2003: China’s economic reforms, especially after Deng Xiaoping’s Southern Tour, shifted from a planned to a “socialist market economy,” with GDP growth averaging over 9% annually — a pace sustained through much of the 1990s and 2000s. (Visual: Animated GDP growth curve, 1991–2025.)
- Late 1990s: The Asian Financial Crisis tested China’s reform resilience; unlike neighbors, China avoided devaluation, bolstering its regional economic stature and setting the stage for WTO accession.
- 2001: China joined the World Trade Organization (WTO), accelerating integration into global supply chains and fueling an export-led boom — exports grew from $266 billion in 2001 to over $2.5 trillion by 2018. (Visual: Export growth map with major trade corridors.)
- 2003: The SARS outbreak exposed weaknesses in China’s public health system, prompting initial investments in disease surveillance and emergency response — a precursor to later COVID-19 infrastructure.
- 2008: The global financial crisis triggered a massive $586 billion stimulus, focused on infrastructure, which stabilized growth but also led to overcapacity and debt in sectors like steel and cement. (Visual: Infrastructure projects timeline.)
- 2010–2025: China’s corporate governance and capital market reforms progressed, but state-owned enterprises (SOEs) retained dominant roles, contributing to both growth and persistent issues like capital misallocation.
- 2013: President Xi Jinping launched the Belt and Road Initiative (BRI), expanding China’s global infrastructure footprint and soft power, with over $1 trillion in pledged investments by 2025.
- 2015: The “Made in China 2025” plan aimed to transform China into a global leader in high-tech industries, with robotics and green tech investments tripling to $1.15 trillion by 2025; domestic market share in priority sectors surged from 50.1% to 78.4%. (Visual: Sectoral investment heatmap.)
- 2015–2025: China’s nominal interest rates fell steadily, with the one-year loan prime rate dropping from 5.3% to 3.1% by May 2025, exacerbating capital misallocation between SOEs and private firms.
- 2016–2020: Anti-corruption campaigns under Xi Jinping targeted both “tigers and flies,” improving bureaucratic discipline but also centralizing political control.
Sources
- https://www.ewadirect.com/proceedings/aemps/article/view/27697
- https://ojs.bonviewpress.com/index.php/JCBAR/article/view/4189
- https://www.cambridge.org/core/product/identifier/9781009509053/type/element
- https://www.ewadirect.com/proceedings/aemps/article/view/24018
- http://jier.org/index.php/journal/article/view/2470
- https://onlinelibrary.wiley.com/doi/10.1111/1758-5899.70054
- https://ssdl.online/images/conf/2025/smartgreens2025/96.pdf
- https://www.vidhyayanaejournal.org/index.php/journal/article/view/2367
- https://globalpresspk.com/index.php/JFATR/article/view/69
- https://onlinelibrary.wiley.com/doi/10.1111/j.1465-7287.1991.tb00344.x